Erectile Dysfunction Drugs: Worldwide Market Forecasts to 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Erectile Dysfunction Drugs Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Erectile Dysfunction Drugs Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Cell Culture Protein Surface Coatings: Global Market Growth, Trends, and Forecasts (2019-2024)” report has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027” report has been added to ResearchAndMarkets.com’s offering. “Plaque…
Only once-daily PARP inhibitor approved in Europe for hereditary breast cancer NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that the…
Only once-daily PARP inhibitor approved in Europe for hereditary breast cancer NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that the…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today presented new preclinical data showing preserved bone health with…
SEATTLE–(BUSINESS WIRE)–#GlucagonlikePeptide1ReceptorAgonist–According to Coherent Market Insights, the global oral biologics market was valued at US$ 834.3 million in 2018, and…
Life sciences credit card provides exclusive savings to CLSA members, including 60,000 bonus points, tailored rewards, dedicated support, and more…
HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal…
SEATTLE–(BUSINESS WIRE)–#CustomRecombinantProtein–According to Coherent Market Insights, the global custom recombinant protein production services market was valued at US$ 2,600.21 million…